| Primary |
| Breast Cancer |
46.2% |
| Gastric Cancer |
23.3% |
| Pain |
3.2% |
| Breast Cancer Metastatic |
2.8% |
| Prophylaxis |
2.8% |
| Invasive Ductal Breast Carcinoma |
2.6% |
| Depression |
2.1% |
| Chemotherapy |
1.8% |
| Anxiety |
1.5% |
| Hepatic Cancer |
1.5% |
| Her-2 Positive Breast Cancer |
1.5% |
| Metastatic Gastric Cancer |
1.3% |
| Nausea |
1.3% |
| Product Used For Unknown Indication |
1.3% |
| Rhabdomyosarcoma |
1.3% |
| Constipation |
1.2% |
| Hypertension |
1.2% |
| Metastatic Neoplasm |
1.2% |
| Adenocarcinoma |
1.0% |
| Gastrooesophageal Cancer |
1.0% |
|
| Pyrexia |
10.0% |
| Vomiting |
10.0% |
| Neutropenic Sepsis |
8.0% |
| General Physical Health Deterioration |
7.0% |
| Neutropenia |
7.0% |
| Chest Pain |
6.0% |
| Febrile Neutropenia |
6.0% |
| Pneumocystis Jiroveci Pneumonia |
5.0% |
| Sepsis |
5.0% |
| Dyspnoea |
4.0% |
| Septic Shock |
4.0% |
| Weight Decreased |
4.0% |
| Anaphylactic Shock |
3.0% |
| Death |
3.0% |
| Interstitial Lung Disease |
3.0% |
| Loss Of Consciousness |
3.0% |
| Malaise |
3.0% |
| Mucosal Inflammation |
3.0% |
| Pleural Effusion |
3.0% |
| Renal Failure Acute |
3.0% |
|
| Secondary |
| Gastric Cancer |
35.3% |
| Breast Cancer |
30.8% |
| Pain |
7.1% |
| Metastatic Gastric Cancer |
5.7% |
| Drug Use For Unknown Indication |
3.4% |
| Nausea |
2.1% |
| Rhabdomyosarcoma |
2.1% |
| Product Used For Unknown Indication |
2.0% |
| Premedication |
1.9% |
| Depression |
1.1% |
| Metastases To Liver |
1.1% |
| Anxiety |
0.9% |
| Hepatic Cancer Metastatic |
0.9% |
| B-cell Lymphoma |
0.8% |
| Constipation |
0.8% |
| Hypertension |
0.8% |
| Adenocarcinoma |
0.7% |
| Breast Cancer Metastatic |
0.7% |
| Breast Cancer Stage Iv |
0.7% |
| Embryonal Rhabdomyosarcoma |
0.7% |
|
| Pyrexia |
12.0% |
| Weight Decreased |
10.2% |
| General Physical Health Deterioration |
9.3% |
| Malignant Neoplasm Progression |
8.3% |
| Neutropenia |
6.5% |
| Acute Myeloid Leukaemia |
4.6% |
| Pulmonary Embolism |
4.6% |
| Renal Failure Acute |
4.6% |
| Sepsis |
4.6% |
| Thrombocytopenia |
4.6% |
| Gastric Cancer |
3.7% |
| Liver Abscess |
3.7% |
| Pancytopenia |
3.7% |
| Ejection Fraction Decreased |
2.8% |
| Febrile Neutropenia |
2.8% |
| Gastrointestinal Haemorrhage |
2.8% |
| Hypothyroidism |
2.8% |
| Nausea |
2.8% |
| Rash |
2.8% |
| Thrombosis |
2.8% |
|
| Concomitant |
| Breast Cancer |
38.9% |
| Metastases To Bone |
13.9% |
| Pancreatic Carcinoma |
13.9% |
| Drug Use For Unknown Indication |
11.1% |
| Metastases To Liver |
8.3% |
| Lymphoproliferative Disorder |
4.2% |
| Uterine Leiomyosarcoma |
4.2% |
| Breast Cancer Metastatic |
1.4% |
| Natural Killer-cell Leukaemia |
1.4% |
| Premedication |
1.4% |
| Prophylaxis Of Nausea And Vomiting |
1.4% |
|
| Tooth Extraction |
27.8% |
| Vomiting |
16.7% |
| Interstitial Lung Disease |
11.1% |
| Liver Abscess |
11.1% |
| Endometrial Cancer |
5.6% |
| Gastrointestinal Haemorrhage |
5.6% |
| Skin Disorder |
5.6% |
| Treatment Noncompliance |
5.6% |
| Type 1 Diabetes Mellitus |
5.6% |
| White Blood Cell Count Decreased |
5.6% |
|
